Stay updated on HER2+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the HER2+ Breast Cancer Clinical Trial page.

Latest updates to the HER2+ Breast Cancer Clinical Trial page
- Check5 days agoChange DetectedFooter now displays Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.3.2 is now shown instead of v3.3.1. There are no changes to the study details, eligibility criteria, or locations.SummaryDifference0.0%

- Check34 days agoChange DetectedMinor editorial updates note that PubMed publications are automatically filled and that the revision number has changed from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedThe banner announcing government funding status/NIH operating status was removed; this informational element did not affect core study content, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check55 days agoChange DetectedSubstantive study details such as design, outcomes, eligibility criteria, and locations appear unchanged. The changes seem limited to layout and formatting only; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check84 days agoChange Detected- Updated operating status notice due to funding lapse and guidance to official status pages. - Version bumped from v3.1.0 to v3.2.0.SummaryDifference2%

Stay in the know with updates to HER2+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HER2+ Breast Cancer Clinical Trial page.